-
公开(公告)号:EP3157909A1
公开(公告)日:2017-04-26
申请号:EP15739054.3
申请日:2015-06-18
发明人: OWENS, Timothy , BRAMELD, Kenneth
IPC分类号: C07D281/08 , C07D417/12 , C07D413/12 , C07D277/24 , C07D249/08 , C07D277/32 , A61K31/4196 , A61K31/42 , A61K31/427 , A61P29/00 , A61P37/00
CPC分类号: C07D417/12 , C07C237/20 , C07D249/08 , C07D261/14 , C07D277/24 , C07D277/32 , C07D277/34 , C07D281/08 , C07D413/12
摘要: The present disclosure provides compounds that are Large Multifunctional Protease 7 (LMP7) inhibitors and are therefore useful for the treatment of diseases treatable by inhibition of LMP7. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
摘要翻译: 本公开提供了大型多功能蛋白酶7(LMP7)抑制剂的化合物,因此可用于治疗可通过抑制LMP7治疗的疾病。 还提供了含有这些化合物的药物组合物以及制备这些化合物的方法。
-
2.TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF 审中-公开
标题翻译: TRKA-KINASE-HEMMER,ZUSAMMENSETZUNGEN DARAUS UND VERFAHRENDAFÜR公开(公告)号:EP3046554A4
公开(公告)日:2017-03-08
申请号:EP14845934
申请日:2014-09-17
申请人: MERCK SHARP & DOHME
发明人: COOKE ANDREW J , STUMP CRAIG A , ZHANG XU-FANG , LI CHUN SING , MAO QINGHUA
CPC分类号: C07D213/75 , C07C275/28 , C07D231/40 , C07D233/88 , C07D239/42 , C07D249/08 , C07D257/04 , C07D261/14 , C07D263/32 , C07D271/10 , C07D277/44 , C07D277/48 , C07D285/12 , C07D295/135 , C07D311/88 , C07D401/04 , C07D403/04 , C07D405/04 , C07D405/12 , C07D471/04 , C07D487/04 , C07D498/04 , C07D513/04
-
公开(公告)号:EP2716635B1
公开(公告)日:2017-02-01
申请号:EP13196679.8
申请日:2010-06-08
发明人: Bartolozzi, Alessandra , Hickey, Eugene Richard , Riether, Doris , Wu, Lifen , Zindell, Renee M. , Blumire, Nigel , Ermann, Nigel , Glenn, Edward , Khor, Someina , Zawadzki, Przemyslaw
IPC分类号: C07D261/14 , C07D413/12 , C07D413/14 , C07D417/06 , C07D417/12 , C07D417/14 , A61K31/42 , A61P29/00
CPC分类号: C07D413/12 , C07D261/14 , C07D413/14 , C07D417/06 , C07D417/12 , C07D417/14
-
4.NITAZOXANIDE AND TIZOXANIDE AS ANTI-VIRAL AGENTS 审中-公开
标题翻译: NITAZOXANIDE UND TIZOXANIDE ALS ANTIVIRALE MITTEL公开(公告)号:EP3078377A2
公开(公告)日:2016-10-12
申请号:EP16167043.5
申请日:2010-05-11
IPC分类号: A61K31/425
CPC分类号: C07D417/12 , A61K31/4196 , A61K31/4245 , A61K31/427 , A61K31/433 , A61K31/454 , A61K31/497 , A61K31/506 , A61K45/06 , C07D231/40 , C07D231/44 , C07D233/88 , C07D233/90 , C07D249/14 , C07D261/14 , C07D263/48 , C07D271/07 , C07D271/113 , C07D275/03 , C07D277/46 , C07D277/56 , C07D285/08 , C07D285/135 , C07D401/12 , C07D403/06 , C07D403/12 , C07D405/12 , C07D409/06 , C07D413/12 , C07D417/06
摘要: A thiazolide compound selected from nitazoxanide and tizoxanide for use in the treatment of a viral infection caused by a virus selected from Sendai virus, Coronavirus, Rhinovirus, Respiratory Syncytial Virus, Herpesvirus, Rotavirus and Adenovirus is described.
摘要翻译: 描述了用于治疗由仙台病毒,冠状病毒,鼻病毒,呼吸道合胞病毒,疱疹病毒,轮状病毒和腺病毒中选择的病毒引起的病毒感染的选择硝唑尼特和替唑尼特的噻唑烷化合物。
-
公开(公告)号:EP3046554A1
公开(公告)日:2016-07-27
申请号:EP14845934.0
申请日:2014-09-17
CPC分类号: C07D213/75 , C07C275/28 , C07D231/40 , C07D233/88 , C07D239/42 , C07D249/08 , C07D257/04 , C07D261/14 , C07D263/32 , C07D271/10 , C07D277/44 , C07D277/48 , C07D285/12 , C07D295/135 , C07D311/88 , C07D401/04 , C07D403/04 , C07D405/04 , C07D405/12 , C07D471/04 , C07D487/04 , C07D498/04 , C07D513/04
摘要: The present invention is directed to benzyl urea compounds of formula (I) which are tropomyosin-related kinase (Trk) family protein kinase inhibitors, and hence may be useful in the treatment of pain, inflammation, cancer, restenosis, atherosclerosis, psoriasis, thrombosis, a disease, disorder, injury, or malfunction relating to dysmyelination or demyelination or a disease or disorder associated with abnormal activities of nerve growth factor (NGF) receptor Trk-A, Trk-B and/or Trk-C.
-
公开(公告)号:EP2970155A1
公开(公告)日:2016-01-20
申请号:EP14729491.2
申请日:2014-03-12
发明人: BALOG, James Aaron , HUANG, Audris , CHEN, Bin , CHEN, Libing , SEITZ, Steven P. , HART, Amy C. , MARKWALDER, Jay A.
IPC分类号: C07D261/02 , C07C233/07 , C07D239/22 , C07D213/60
CPC分类号: A61K31/196 , A61K31/18 , A61K31/216 , A61K31/27 , A61K31/36 , A61K31/41 , A61K31/42 , A61K31/4245 , A61K31/44 , A61K31/498 , A61K31/505 , A61K45/06 , A61N5/10 , C07B2200/07 , C07C69/743 , C07C233/55 , C07C235/38 , C07C255/44 , C07C255/57 , C07C271/28 , C07C275/42 , C07C311/47 , C07C311/51 , C07C2601/02 , C07C2601/08 , C07C2601/14 , C07C2602/02 , C07C2602/08 , C07C2602/14 , C07C2602/42 , C07D213/56 , C07D213/75 , C07D213/84 , C07D239/42 , C07D241/42 , C07D257/04 , C07D261/08 , C07D261/14 , C07D271/12 , C07D317/66 , Y02A50/411 , Y02A50/414
摘要: There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.
摘要翻译: 公开了调节或抑制吲哚胺2,3-双加氧酶(IDO)的酶活性的化合物,含有所述化合物的药物组合物和使用所述化合物治疗增殖性疾病如癌症,病毒感染和/或炎症性疾病的方法 发明。
-
7.COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS 审中-公开
标题翻译: VERBINDUNGEN UND VERFAHREN ZUR INDUKTION VON CHONDROGENESE公开(公告)号:EP2968330A1
公开(公告)日:2016-01-20
申请号:EP14770543.8
申请日:2014-03-13
发明人: SCHULTZ, Peter, G. , CHATTERJEE, Arnab, K. , ZHU, Shoutian , PAYETTE, Joshua , YOON, Hongchul , YANG, Baiyuan
IPC分类号: A61K31/505 , A61K39/395
CPC分类号: A61K31/54 , A61K31/18 , A61K31/192 , A61K31/194 , A61K31/196 , A61K31/24 , A61K31/255 , A61K31/27 , A61K31/277 , A61K31/357 , A61K31/36 , A61K31/365 , A61K31/402 , A61K31/4035 , A61K31/415 , A61K31/4164 , A61K31/42 , A61K31/426 , A61K31/433 , A61K31/44 , A61K31/495 , A61K31/5375 , A61K45/06 , C07C233/66 , C07C233/69 , C07C233/73 , C07C233/75 , C07C233/76 , C07C233/80 , C07C233/81 , C07C233/87 , C07C235/52 , C07C235/60 , C07C235/84 , C07C237/22 , C07C251/48 , C07C255/60 , C07C271/20 , C07C275/42 , C07C311/05 , C07C311/08 , C07C311/13 , C07C311/17 , C07C311/21 , C07C311/24 , C07C311/46 , C07C317/40 , C07D207/27 , C07D209/46 , C07D209/48 , C07D213/79 , C07D231/40 , C07D233/64 , C07D261/14 , C07D277/46 , C07D285/135 , C07D295/26 , C07D307/88 , C07D317/28 , C07D317/66 , C07D319/08 , C07D319/18 , C12N5/0655 , C12N2506/1353 , A61K2300/00
摘要: Described herein are compounds and compositions for the amelioration of arthritis or joint injuries by inducing mesenchymal stem cells into chondrocytes.
摘要翻译: 本文描述了通过将间充质干细胞诱导成软骨细胞来改善关节炎或关节损伤的化合物和组合物。
-
8.NOVEL ANTIVIRAL AGENTS AGAINST HBV INFECTION 审中-公开
标题翻译: NEUARTIGE ANTIVIRALE WIRKSTOFFE GEGEN HBV-INFEKTION公开(公告)号:EP2938338A2
公开(公告)日:2015-11-04
申请号:EP13868405.5
申请日:2013-12-27
发明人: BAUGH, Simon David Peter , YE, Hong , XU, Xiaodong , GUO, Ju-tao , XIAO, Tong , DU, Yanming , BLOCK, Timothy
IPC分类号: A61K31/165 , A61K31/18
CPC分类号: C07C311/16 , C07B2200/07 , C07C233/66 , C07C309/89 , C07C311/17 , C07C311/18 , C07C311/19 , C07C311/20 , C07C311/48 , C07C317/14 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2601/14 , C07D203/26 , C07D205/04 , C07D211/96 , C07D213/40 , C07D213/75 , C07D213/76 , C07D215/38 , C07D215/42 , C07D217/24 , C07D231/40 , C07D231/42 , C07D239/26 , C07D261/14 , C07D263/48 , C07D263/50 , C07D263/58 , C07D277/46 , C07D277/52 , C07D295/26 , C07D295/30 , C07D295/32 , C07D305/08 , C07D309/04 , C07D319/16 , C07D319/18
摘要: The present invention provides novel compounds of formula (I) and methods of use thereof. In certain embodiments, the compounds of the invention are useful as nucleocapsid assembly inhibitors. In other embodiments, the compounds of the invention are useful as pregenomic RNA encapsidation inhibitors of Hepatitis B virus (HBV). In yet other embodiments, the compounds of the invention are useful for the treatment of viral infection, including HBV and related viral infections.
摘要翻译: 本发明提供新的式(I)化合物及其使用方法。 在某些实施方案中,本发明的化合物可用作核衣壳组装抑制剂。 在其它实施方案中,本发明的化合物可用作乙型肝炎病毒(HBV)的前基因组RNA包封抑制剂。 在其它实施方案中,本发明的化合物可用于治疗病毒感染,包括HBV和相关病毒感染。
-
公开(公告)号:EP2595959B1
公开(公告)日:2015-11-04
申请号:EP11740762.7
申请日:2011-07-18
IPC分类号: C07D213/74 , C07D231/38 , C07D261/14 , C07D277/46 , C07D413/12 , C07D285/135 , A61K31/44 , A61K31/415 , A61K31/41 , A61P29/00
CPC分类号: C07D285/135 , C07D213/74 , C07D231/38 , C07D261/14 , C07D261/18 , C07D277/46 , C07D413/12
-
公开(公告)号:EP2872493A2
公开(公告)日:2015-05-20
申请号:EP13817021.2
申请日:2013-07-12
申请人: Indiana University Research and Technology Corporation , The Brigham and Women's Hospital, Inc. , The University of Massachusetts
IPC分类号: C07D261/06 , C07D413/12 , A61K31/42 , A61P21/00
CPC分类号: C07D493/04 , C07C311/37 , C07C2601/08 , C07C2603/20 , C07D213/75 , C07D215/227 , C07D215/44 , C07D221/10 , C07D231/14 , C07D233/88 , C07D239/47 , C07D239/82 , C07D261/06 , C07D261/14 , C07D261/18 , C07D263/48 , C07D267/14 , C07D277/46 , C07D285/135 , C07D401/04 , C07D405/04 , C07D405/12 , C07D413/12 , C07D417/04 , C07D417/12 , C07D471/04 , C07D487/04 , C07K14/47
摘要: Disclosed herein are compositions and methods for treatment of spinal muscular atrophy (SMA). In certain embodiments, compounds are provided that increase full-length survival of motor neuron (SMN) protein production by an SMN2 gene.
摘要翻译: 本文公开了用于治疗脊髓性肌萎缩(SMA)的组合物和方法。 在某些实施方案中,提供了增加SMN2基因产生的运动神经元(SMN)蛋白质生产的全长存活的化合物。
-
-
-
-
-
-
-
-
-